Mercer Global Advisors
IDNA icon

Mercer Global Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Mercer Global Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68 Buy
+2
New +$60 ﹤0.01% 5993

Other funds holding IDNA

WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.36B AUM 18.79% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PCA
Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 23.67% 1-Year Est. Return

Mercer Global Advisors's IDNA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2026: 2 shares worth $68. The stake represents ﹤0.01% of the portfolio and ranks #5993 among its holdings.

41 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Mercer Global Advisors held 2 shares of iShares Genomics Immunology and Healthcare ETF worth $68 as of Q2 2026.
  • iShares Genomics Immunology and Healthcare ETF was a new Mercer Global Advisors position in Q2 2026.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5993 holding.
  • 41 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.